Abstract:Objective Lectin-like Ox-LDL receptor-1 (LOX-1), a novel vascular receptor for oxidized LDL, is responsible for recognition and internalization of ox-LDL in vascular cells. It also mediates a spectrum of pro-atherogenic cellular responses implicated in the development and progression of atherosclerosis including endothelial dysfunction and apoptosis, vascular inflammation, foam cell formation and collagen deposition. Previous studies revealed that expression of LOX-1 was highly inducible by proinflammatory stimuli, such as tumor necrosis factor-alpha (TNF-α), Ox-LDL and lipopolysaccharide (LPS). We have demonstrated that tanshinone II-A (a diterpene flavonoids isolated from Tanshen) supplementation retarded the atherogenesis progression in ApoE knockout mice via inhibition of LOX-1 expression. Therefore, we hypothesized that tanshinone II-A could also inhibit LOX-1 expression induced by pro-inflammatory stimuli in murine macrophages. Design and Methods RAW264.7 cells and murine peritoneal macrophages were cultured. Quantitative real-time PCR and western blot were used to determine LOX-1 gene and protein expression. Electrophoretic mobility shift assay (EMSA) was performed to demonstrate the nuclear protein binding to NF-κB regulatory element of LOX-1 gene. Results Pretreatment of cultured macrophages with tanshinone II-A inhibited LOX-1 expression induced by Ox-LDL at both protein and mRNA levels in a time- and concentration-dependent manner. The inhibitory effect was also observed in the cells treated with antioxidants or inhibitors of nuclear factor-kappaB (NF-κB). The activation of NF-κB and phosphorylation of inhibitory factor of NF-kappaB-α (IκB-α) induced by Ox-LDL were suppressed by tanshinone II-A in a time- and concentration-dependent fashion. Ox-LDL also enhanced the binding of nuclear protein to NF-κB regulatory element of LOX-1 gene promoter. This effect was abrogated by tanshinone II-A. Furthermore, the DiI-Ox-LDL uptake study demonstrated that tanshinone II-A concentration-dependently diminished Ox-LDL uptake by macrophages. Conclusions Tanshinone II-A suppressed Ox-LDL-induced LOX-1 expression and the subsequent macrophage foam cell formation, by inhibiting NF-κB activation and ROS generation.

Lanatoside C Promotes Foam Cell Formation and Atherosclerosis

Dietary Sterols and Sterol Oxidation Products on Atherosclerosis: an Insight Provided by Liver Proteomic and Lipidomic.

Folic Acid Delays Development of Atherosclerosis in Low‐density Lipoprotein Receptor‐deficient Mice

Xiaoyaosan Prevents Atherosclerotic Vulnerable Plaque Formation Through Heat Shock Protein/glucocorticoid Receptor Axis-Mediated Mechanism.

Araloside C Attenuates Atherosclerosis by Modulating Macrophage Polarization Via Sirt1-mediated Autophagy

TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression

Enhancing PPARγ by HDAC Inhibition Reduces Foam Cell Formation and Atherosclerosis in ApoE Deficient Mice

SIRT1 inhibition promotes atherosclerosis through impaired autophagy.

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis

SPA Promotes Atherosclerosis Through Mediating Macrophage Foam Cell Formation-Brief Report

Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis

Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through toll-like receptor-4

Perfluorooctane sulfonate promotes atherosclerosis by modulating M1 polarization of macrophages through the NF-κB pathway

LRPPRC Inhibits Autophagy and Promotes Foam Cell Formation in Atherosclerosis

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway

Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway

Tanshinone II-A Inhibited Oxidized Low-Density-Lipoprotein Induced LOX-1 Expression in Murine Macrophages by Reduction of Intracellular Reactive Oxygen Species (ROS) and NF-KappaB Activation

Abstract: P1122 EFFECTS OF MACROPHAGE ABCA7 DEFICIENCY ON LIPID METABOLISM AND THE DEVELOPMENT OF ATHEROSCLEROSIS IN LDL RECEPTOR KNOCKOUT MICE

LncRNA AC096664.3/PPAR‐γ/ABCG1‐dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis